0000929638-25-002339.txt : 20250627 0000929638-25-002339.hdr.sgml : 20250627 20250627094056 ACCESSION NUMBER: 0000929638-25-002339 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20250627 DATE AS OF CHANGE: 20250627 EFFECTIVENESS DATE: 20250627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MPM BioImpact Innovations Equities Master, LP CENTRAL INDEX KEY: 0002028760 ORGANIZATION NAME: EIN: 992009456 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-517266 FILM NUMBER: 251082707 BUSINESS ADDRESS: STREET 1: 399 BOYLSTON STREET, SUITE 1100 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-425-9200 MAIL ADDRESS: STREET 1: 399 BOYLSTON STREET, SUITE 1100 CITY: BOSTON STATE: MA ZIP: 02116 D/A 1 primary_doc.xml X0708 D/A LIVE 0002028760 MPM BioImpact Innovations Equities Master, LP 399 BOYLSTON STREET, SUITE 1100 BOSTON MA MASSACHUSETTS 02116 617-425-9200 DELAWARE None None Limited Partnership true 2024 n/a MPM BioImpact Innovations Equities GP, LLC 399 Bolyston Street, Suite 1100 Boston MA MASSACHUSETTS 02116 Executive Officer The General Partner of the Issuer. Christiana Goh Bardon 399 Boylston Street, Suite 1100 Boston MA MASSACHUSETTS 02116 Executive Officer Dr. Bardon is the Managing Member of the General Partner of the Issuer and the Co-Managing Partner of MPM BioImpact LLC, the Investment Manager of the Issuer. Kristen Laguerre 399 Boylston Street, Suite 1100 Boston MA MASSACHUSETTS 02116 Executive Officer Ms. Laguerre is the Partner, Finance and Operations and Authorized Signatory of the General Partner of the Issuer Christopher Wolf 399 Boylston Street, Suite 1100 Boston MA MASSACHUSETTS 02116 Executive Officer Mr. Wolf is the Chief Financial Officer and Authorized Signatory of the General Partner of the Issuer Pooled Investment Fund Hedge Fund true Decline to Disclose 3C.7 06b 3C true 0000929638-24-002291 2024-06-03 true true true Limited Partnership Interests. The General Partner, in its sole and absolute discretion, may accept investments of less than the $1,000,000 minimum. false 0 Indefinite 131071230 Indefinite The total amount sold and number of investors reflect only sales to residents of the U.S. false 7 0 0 0 false MPM BioImpact Innovations Equities Master, LP /s/ Christopher Wolf Christopher Wolf Authorized Signatory of the General Partner of the Issuer 2025-06-25